IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Crestline Management, L.P.

Q2 2025 Holdings

Filed 2025-08-14 | 3 holdings | $62.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Denali Therapeutics Inc(DNLI)COM24823R105$54.0M3,860,73286.3%
Sana Biotechnology Inc(SANA)COM799566104$6.6M2,420,93710.6%
8X8 Inc New(EGHT)COM282914100$1.9M990,5803.1%